WO1999006831A3 - Breast cancer resistance genes, methods for their detection and uses thereof - Google Patents
Breast cancer resistance genes, methods for their detection and uses thereof Download PDFInfo
- Publication number
- WO1999006831A3 WO1999006831A3 PCT/EP1998/004754 EP9804754W WO9906831A3 WO 1999006831 A3 WO1999006831 A3 WO 1999006831A3 EP 9804754 W EP9804754 W EP 9804754W WO 9906831 A3 WO9906831 A3 WO 9906831A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- breast cancer
- methods
- detection
- resistance genes
- cancer resistance
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU90710/98A AU9071098A (en) | 1997-07-29 | 1998-07-29 | Breast cancer resistance genes, methods for their detection and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5410197P | 1997-07-29 | 1997-07-29 | |
US60/054,101 | 1997-07-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999006831A2 WO1999006831A2 (en) | 1999-02-11 |
WO1999006831A9 WO1999006831A9 (en) | 1999-07-29 |
WO1999006831A3 true WO1999006831A3 (en) | 1999-09-02 |
Family
ID=21988820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/004754 WO1999006831A2 (en) | 1997-07-29 | 1998-07-29 | Breast cancer resistance genes, methods for their detection and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU9071098A (en) |
WO (1) | WO1999006831A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO972006D0 (en) | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | New method for diagnosis of diseases |
US6891022B1 (en) | 1998-04-23 | 2005-05-10 | Genentech, Inc. | NSP molecules |
EP1071773A1 (en) * | 1998-04-23 | 2001-01-31 | Genentech, Inc. | Sh2 domain-containing peptides |
GB0412301D0 (en) | 2004-06-02 | 2004-07-07 | Diagenic As | Product and method |
FR2881830B1 (en) * | 2005-02-09 | 2007-05-04 | Ct De Rech Pour Les Pathologie | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROSTATE CANCER |
WO2007073774A1 (en) * | 2005-12-23 | 2007-07-05 | Universita' Degli Studi Di Torino | Genotoxic testing |
WO2010009171A2 (en) * | 2008-07-14 | 2010-01-21 | Wyeth | Src activation for determining cancer prognosis and as a target for cancer therapy |
EP2669682B1 (en) | 2012-05-31 | 2017-04-19 | Heinrich-Heine-Universität Düsseldorf | Novel prognostic and predictive biomarkers (tumor markers) for human breast cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992003973A1 (en) * | 1990-09-05 | 1992-03-19 | Board Of Regents, The University Of Texas System | Onset of antiestrogen resistance in breast cancer |
US5292638A (en) * | 1990-12-07 | 1994-03-08 | The Regents Of The University Of California | Method of determining functional estrogen receptors for prognosis of cancer |
-
1998
- 1998-07-29 WO PCT/EP1998/004754 patent/WO1999006831A2/en active Application Filing
- 1998-07-29 AU AU90710/98A patent/AU9071098A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992003973A1 (en) * | 1990-09-05 | 1992-03-19 | Board Of Regents, The University Of Texas System | Onset of antiestrogen resistance in breast cancer |
US5292638A (en) * | 1990-12-07 | 1994-03-08 | The Regents Of The University Of California | Method of determining functional estrogen receptors for prognosis of cancer |
Non-Patent Citations (4)
Title |
---|
DORSSERS, L. C. J. ET AL: "Identification and cloning of a human breast cancer antiestrogen resistance locus (bcar1) by provirus insertion mutagenesis.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, (1993) VOL. 34, NO. 0, PP. 497. MEETING INFO.: 84TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ORLANDO, FLORIDA, USA MAY 19-22, 1993 ISSN: 0197-016X., XP002091638 * |
DORSSERS, L.C.J. ET AL.,: "Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: Identification of bcar-1, a common integration site.", MOLECULAR ENDOCRINOLOGY, vol. 7, no. 7, - 1993, pages 870-878, XP002091641 * |
VAN AGTHOVEN, T. ET AL.,: "Ectopic expression of epidermal growth factor receptors induces hormone independence in zr-75-1 human breast cancer cells.", CANCER RESEARCH, vol. 52, 1992, pages 5082 - 5088, XP002091640 * |
VAN DER FLIER S ET AL: "Identification of the gene within the bcar1 locus causing antiestrogen resistance in human breast cancer cells in vitro (Meeting abstract).", PROC ANNU MEET AM ASSOC CANCER RES, (1996). VOL. 37, PP. A1596., XP002091639 * |
Also Published As
Publication number | Publication date |
---|---|
AU9071098A (en) | 1999-02-22 |
WO1999006831A9 (en) | 1999-07-29 |
WO1999006831A2 (en) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20170268068A1 (en) | Method for discrimination of metaplasias from neoplastic or preneoplastic lesions | |
Krause et al. | Rapid microfluidic immunoassays of cancer biomarker proteins using disposable inkjet-printed gold nanoparticle arrays | |
WO2001094632A3 (en) | Highly sensitive gene detection and localization using in situ branched-dna hybridization | |
WO2002035232A3 (en) | Method for detecting ovarian cancer based on human kallikrein 6 (hk6) | |
WO2002037112A3 (en) | Detection of ovarian cancer | |
EP3414342B1 (en) | Magnetic beads-based electrochemical biosensor | |
EP0794261A3 (en) | Methods for detection and discrimination of multiple analytes using fluorescent technology | |
EP2189791A3 (en) | Microarrays and uses therefor | |
WO2004046687A3 (en) | Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates | |
WO2004000884A3 (en) | Compositions and methods for apo-b48 and apo-b100 assay | |
AU1010688A (en) | Diagnostic assays using nucleic acid probes | |
WO2000026668A3 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
CA2322023A1 (en) | A novel method of detecting and monitoring endometrial and uterine cancers | |
WO1999006831A3 (en) | Breast cancer resistance genes, methods for their detection and uses thereof | |
KR20130046457A (en) | Newly identified colorectal cancer marker genes, proteins translated from the genes and a diagnostic kit using the same | |
EP3036341B1 (en) | Detection of nucleic acid amplification in a porous substrate | |
KR101492024B1 (en) | Markers for diagnosis of metastatic brain tumor | |
WO2005056829A3 (en) | Method for diagnosis/prognosis of breast cancer | |
WO2001091629A3 (en) | Methods for detecting dna damage and screening for cancer therapeutics | |
CA2375503A1 (en) | An assay for the determination of newly synthesised antibodies in lymphocytes | |
KR20080100925A (en) | A diagnostic composition for diabetes , a diagnostic kit comprising it and diagnostic methods of diabetes | |
CN104634919A (en) | Instant qualitative analysis method for multiple targets | |
EP3183366B1 (en) | Systems and methods of detecting solid tumor cancer | |
WO2001065262A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
EP1387173A1 (en) | Method for improved diagnosis of cervical lesions based on detection of INK4a gene products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/19-19/19, DRAWINGS, ADDED; PAGES 1-24, SEQUENCE LISTING, ADDED |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09492445 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |